Abbott Company Profile

What is the competitive landscape for ABBOTT

ABBOTT has one hundred and eleven approved drugs.

Summary for Abbott

US Patents:	0
Tradenames:	89
Ingredients:	62
NDAs:	111
Patent Litigation for Abbott:	See patent lawsuits for Abbott

Drugs and US Patents for Abbott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-002	Aug 7, 1987		DISCN	No	No
Abbott	AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019713-003	Sep 9, 1988		DISCN	No	No
Abbott	A-POXIDE	chlordiazepoxide hydrochloride	CAPSULE;ORAL	085517-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Abbott	FENTANYL CITRATE	fentanyl citrate	INJECTABLE;INJECTION	070637-001	Apr 30, 1990		DISCN	No	No
Abbott	MEPERIDINE HYDROCHLORIDE	meperidine hydrochloride	INJECTABLE;INJECTION	080387-001	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Abbott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-004	Dec 14, 1994	5,294,615
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-002	Aug 7, 1987	5,412,095
Abbott	HYTRIN	terazosin hydrochloride	CAPSULE;ORAL	020347-002	Dec 14, 1994	4,251,532
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-004	Aug 7, 1987	5,212,176
Abbott	HYTRIN	terazosin hydrochloride	TABLET;ORAL	019057-001	Aug 7, 1987	4,251,532

Paragraph IV (Patent) Challenges for ABBOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Capsules	10 mg and 15 mg		2009-08-14
	Capsules	100 mg		2012-10-31
	Tablets	100 mg		2010-12-21

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Abbott
• Abbott Labs